(b).
Condition | Reference | Sample | Prevalence |
---|---|---|---|
Associated conditions | |||
| |||
Obesity | Ehrmann et al. [41] | 394 | 80% |
Hahn et al. [40] | 200 | 52% | |
Azziz et al. [42] | 267 | 42% | |
| |||
Insulin resistance | Carmina and Lobo [43] | 267 | 77% |
Hahn et al. [40] | 200 | 71% | |
| |||
Impaired fasting glucose | Ehrmann et al. [41] | 122 | 35% |
Legro et al. [44] | 254 | 31.1% | |
| |||
Type 2 diabetes mellitus | Legro et al. [44] | 254 | 7.5% |
Ehrmann et al. [41] | 394 | 6.6% | |
| |||
Arterial hypertension | Ehrmann et al. [41] | 394 | 21% |
Elting et al. [45] | 346 | 9% | |
| |||
Dyslipidemia | Hahn et al. [40] | 200 | 46.3% |
Ehrmann et al. [41] | 394 | 32% | |
| |||
Metabolic syndrome | Dokras et al. [46] | 129 | 47.3% |
Apridonidze et al. [13] | 106 | 43% | |
| |||
Mood disorders | Jedel et al. [36] | 30 | 53% |
Hollinrake et al. [47] | 103 | 21% |
All studies cited were carried out in adults.